In a 2023 study, a self-amplified biomimetic nanosystem, mEHGZ, was constructed by encapsulation of epirubicin (EPI), glucose oxidase (Gox) and hemin in ZIF-8 nanoparticles and coating them with calreticulin (CRT) over-expressed tumor cell membrane. The gene discussed is CALR; the disease is neoplasm.